Results 201 to 210 of about 433,059 (284)

Aptamer-ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy. [PDF]

Cells
Xia B, Zhu Q.
europepmc   +1 more source

Proteomics profiling of research models for studying pancreatic ductal adenocarcinoma. [PDF]

Sci Data
Resell M, Rabben HL, Sharma A, Hagen L, Hoang L, Skogaker NT, Aarvik A, Bjåstad EK, Svensson MK, Amrutkar M, Verbeke CS, Batra SK, Qvigstad G, Wang TC, Rustgi A, Chen D, Zhao CM.   +16 more
europepmc   +1 more source

Immunomodulatory behavior of CircRNAs in tumor microenvironment. [PDF]

Oncol Res
Liang H, Yan W, Liu Z, He Y, Hu J, Shu Z, Li H, Othmane B, Ren W, Quan C, Qiu D, Chen M, Xiong W, Zhang B, Liu P.   +14 more
europepmc   +1 more source

Expression of an extracellular ribonuclease gene increases resistance to in tobacco [PDF]

core   +1 more source

Altered levels of angiogenin and tRNA-derived fragments associate with severe asthma. [PDF]

Sci Rep
Claus C, Grosso JB, Maraval MB, Ardusso M, Bottasso OA, Maes T, Bracke K, Brusselle G, Ibañez M, Ardusso LRF, Spinelli SV.   +10 more
europepmc   +1 more source

DDX21 Controls Cell Cycle Progression and Autophagy in Pancreatic Cancer Cells. [PDF]

Cancers (Basel)
Leccese A, Ruta V, Panzeri V, Attili F, Spada C, Cianfanelli V, Sette C.   +6 more
europepmc   +1 more source

Impact of Hypothermic Perfusion on Immune Responses and Sterile Inflammation in a Preclinical Model of Pancreatic Transplantation. [PDF]

Transplant Direct
Mesnard B, Bruneau S, Le Bas-Bernardet S, Ogbemudia E, Kervella D, Masset C, Neel M, Minault MD, Hervouet MJ, Cantarovich D, Rigaud J, Badet L, Friend P, Ploeg R, Blancho G, Hunter J, Prudhomme T, Branchereau J.   +17 more
europepmc   +1 more source

Exploring the potential of gemcitabine-metal-organic frameworks in combating pancreatic cancer under ketogenic conditions. [PDF]

BMC Cancer
Nekoufar S, Ghorbani M, Safaei S, Khosroushahi GA, Shirian FI, Baradaran B, Tavakoli-Yaraki M.   +6 more
europepmc   +1 more source

Cobra Three-Finger Toxins Interact with RNA and DNA: Nucleic Acids as Their Putative Biological Targets. [PDF]

Int J Mol Sci
Osipov AV, Starkov VG, Tsetlin VI, Utkin YN.   +3 more
europepmc   +1 more source

Reversing regulatory safeguards: Targeting the ATR pathway to overcome PARP inhibitor resistance. [PDF]

Mol Ther Oncol
Lin X, Qiu Y, Soni A, Stuschke M, Iliakis G.   +4 more
europepmc   +1 more source